BioDelivery Sciences to Present at Rodman & Renshaw, Baird, and Stifel Nicolaus Investor Conferences

BioDelivery Sciences International, Inc. BDSI today announced its participation at three upcoming investor conferences. Dr. Mark A. Sirgo, President and Chief Executive Officer, will present at each conference where he will focus on BDSI’s product pipeline, including BEMA Buprenorphine for pain and opioid dependence, and BEMA Granisetron for the prevention of chemotherapy induced nausea and vomiting. Rodman & Renshaw Annual Global Investment Conference Monday, September 13 at 3:40 p.m. Eastern Time New York Palace Hotel, New York City. Baird 2010 Healthcare Conference Wednesday, September 15 at 9:00 a.m. Eastern Time St. Regis New York, New York City. Stifel Nicolaus 2010 Healthcare Conference Thursday, September 16 at 10:55 a.m. Eastern Time Four Seasons Hotel, Boston. Each presentation will be webcast live and can be accessed at www.bdsi.com. For those who are not available to listen to the live broadcast, the presentations will be archived.